197 related articles for article (PubMed ID: 36599262)
21. Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans.
Du Z; Gjertson DW; Reed EF; Rajalingam R
Immunogenetics; 2007 Jan; 59(1):1-15. PubMed ID: 17103212
[TBL] [Abstract][Full Text] [Related]
22. KIR-HLA-A and B alleles of the Bw4 epitope against HIV infection in discordant heterosexual couples in Chaco Argentina.
Habegger de Sorrentino A; Sinchi JL; Marinic K; López R; Iliovich E
Immunology; 2013 Oct; 140(2):273-9. PubMed ID: 23789883
[TBL] [Abstract][Full Text] [Related]
23. The impact of KIR-HLA genotype on hepatitis B virus clearance in Iranian infected individuals.
Shah-Hosseini A; Jafari M; Mohammadi A; Sanaei R; Alavian SM; Doosti-Irani A; Nooradeh Keykavousi M; Tajik N
Med Microbiol Immunol; 2017 Dec; 206(6):463-470. PubMed ID: 29032460
[TBL] [Abstract][Full Text] [Related]
24. The distribution of KIR-HLA functional blocks is different from north to south of Italy.
Fasano ME; Rendine S; Pasi A; Bontadini A; Cosentini E; Carcassi C; Capittini C; Cornacchini G; Espadas de Arias A; Garbarino L; Carella G; Mariotti ML; Mele L; Miotti V; Moscetti A; Nesci S; Ozzella G; Piancatelli D; Porfirio B; Riva MR; Romeo G; Tagliaferri C; Lombardo C; Testi M; Amoroso A; Martinetti M
Tissue Antigens; 2014 Mar; 83(3):168-73. PubMed ID: 24571475
[TBL] [Abstract][Full Text] [Related]
25. [Association of genetic polymorphisms of KIR-HLA system with chronic myeloid leukemia among ethnic Hans from southern China].
Deng Z; Zhen J; Wang D; He L; Zou H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Feb; 34(1):53-57. PubMed ID: 28186594
[TBL] [Abstract][Full Text] [Related]
26. Activating and inhibitory killer cell immunoglobulin like receptors (KIR) genes are involved in an increased susceptibility to colorectal adenocarcinoma and protection against invasion and metastasis.
Barani S; Hosseini SV; Ghaderi A
Immunobiology; 2019 Sep; 224(5):681-686. PubMed ID: 31248612
[TBL] [Abstract][Full Text] [Related]
27. KIR-HLA gene diversities and susceptibility to lung cancer.
Hematian Larki M; Ashouri E; Barani S; Ghayumi SMA; Ghaderi A; Rajalingam R
Sci Rep; 2022 Oct; 12(1):17237. PubMed ID: 36241658
[TBL] [Abstract][Full Text] [Related]
28. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.
Lorentzen AR; Karlsen TH; Olsson M; Smestad C; Mero IL; Woldseth B; Sun JY; Senitzer D; Celius EG; Thorsby E; Spurkland A; Lie BA; Harbo HF
Ann Neurol; 2009 Jun; 65(6):658-66. PubMed ID: 19630074
[TBL] [Abstract][Full Text] [Related]
29. KIR2DS3 is associated with protection against acute myeloid leukemia.
Shahsavar F; Tajik N; Entezami KZ; Fallah Radjabzadeh M; Asadifar B; Alimoghaddam K; Ostadali Dahaghi M; Jalali A; Ghashghaie A; Ghavamzadeh A
Iran J Immunol; 2010 Mar; 7(1):8-17. PubMed ID: 20371915
[TBL] [Abstract][Full Text] [Related]
30. Individualized Constellation of Killer Cell Immunoglobulin-Like Receptors and Cognate HLA Class I Ligands that Controls Natural Killer Cell Antiviral Immunity Predisposes COVID-19.
Maruthamuthu S; Rajalingam K; Kaur N; Morvan MG; Soto J; Lee N; Kong D; Hu Z; Reyes K; Ng D; Butte AJ; Chiu C; Rajalingam R
Front Genet; 2022; 13():845474. PubMed ID: 35273641
[No Abstract] [Full Text] [Related]
31. Impact of donor KIRs and recipient KIR/HLA class I combinations on GVHD in patients with acute leukemia after HLA-matched sibling HSCT.
Mansouri M; Villard J; Ramzi M; Alavianmehr A; Farjadian S
Hum Immunol; 2020 Jun; 81(6):285-292. PubMed ID: 32199702
[TBL] [Abstract][Full Text] [Related]
32. Positive association of Bx genotype, KIR2L5, KIR2DS5 and full-length KIR2DS4 with the risk of meningioma.
Barani S; Taghipour M; Ghaderi A
Immunobiology; 2020 Mar; 225(2):151900. PubMed ID: 31899050
[TBL] [Abstract][Full Text] [Related]
33. Genetic diversity of the KIR/HLA system and outcome of patients with metastatic colorectal cancer treated with chemotherapy.
De Re V; Caggiari L; De Zorzi M; Talamini R; Racanelli V; D' Andrea M; Buonadonna A; Zagonel V; Cecchin E; Innocenti F; Toffoli G
PLoS One; 2014; 9(1):e84940. PubMed ID: 24497922
[TBL] [Abstract][Full Text] [Related]
34. Co-evolution of human leukocyte antigen (HLA) class I ligands with killer-cell immunoglobulin-like receptors (KIR) in a genetically diverse population of sub-Saharan Africans.
Norman PJ; Hollenbach JA; Nemat-Gorgani N; Guethlein LA; Hilton HG; Pando MJ; Koram KA; Riley EM; Abi-Rached L; Parham P
PLoS Genet; 2013 Oct; 9(10):e1003938. PubMed ID: 24204327
[TBL] [Abstract][Full Text] [Related]
35. Diversity and association of HLA/KIR receptors with type 2 diabetes in South India.
Chinniah R; Vijayan M; Sivanadham R; Ravi P; Panneerselvam D; Kannan A; Karuppiah B
Int J Immunogenet; 2019 Jun; 46(3):166-178. PubMed ID: 30809938
[TBL] [Abstract][Full Text] [Related]
36. Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study.
Varbanova VP; Mihailova S; Naumova E; Mihaylova AP
Turk J Haematol; 2019 Nov; 36(4):238-246. PubMed ID: 31337191
[TBL] [Abstract][Full Text] [Related]
37. Understanding the killer-cell immunoglobulin like receptor polymorphism in retinoblastoma.
Aggarwal R; Sharma M; Singh U; Poulton K; Bhatia T; Mangat N; Kakkar N; Bansal D
Ophthalmic Genet; 2023 Feb; 44(1):1-5. PubMed ID: 36594723
[TBL] [Abstract][Full Text] [Related]
38. HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke.
Tuttolomondo A; Di Raimondo D; Pecoraro R; Casuccio A; Di Bona D; Aiello A; Accardi G; Arnao V; Clemente G; Corte VD; Maida C; Simonetta I; Caruso C; Squatrito R; Pinto A;
J Neuroinflammation; 2019 Apr; 16(1):88. PubMed ID: 30995924
[TBL] [Abstract][Full Text] [Related]
39. HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugs.
Thöns C; Senff T; Hydes TJ; Manser AR; Heinemann FM; Heinold A; Heilmann M; Kim AY; Uhrberg M; Scherbaum N; Lauer GM; Khakoo SI; Timm J
J Hepatol; 2017 Sep; 67(3):462-470. PubMed ID: 28412292
[TBL] [Abstract][Full Text] [Related]
40. Analysis of KIR gene frequencies and HLA class I genotypes in prostate cancer and control group.
Portela P; Jobim LF; Salim PH; Koff WJ; Wilson TJ; Jobim MR; Schwartsmann G; Roesler R; Jobim M
Int J Immunogenet; 2012 Oct; 39(5):423-8. PubMed ID: 22487023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]